Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis

Molecular targeted agents are pharmacologically used to treat liver fibrosis and have gained increased attention. The present study examined the preventive effect of lenvatinib on experimental liver fibrosis and sinusoidal capillarization as well as the in vitro phenotypes of hepatic stellate cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Hiroyuki, Kaji, Kosuke, Nishimura, Norihisa, Takagi, Hirotetsu, Ishida, Koji, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051749/
https://www.ncbi.nlm.nih.gov/pubmed/33609067
http://dx.doi.org/10.1111/jcmm.16363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051749/
https://www.ncbi.nlm.nih.gov/pubmed/33609067
http://dx.doi.org/10.1111/jcmm.16363

Ejemplares similares